[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

B Streptococcus (GBS) Infection Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: BAD312A9C007EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of B Streptococcus (GBS) Infection Treatment in Global, including the following market information:

Global B Streptococcus (GBS) Infection Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global B Streptococcus (GBS) Infection Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the B Streptococcus (GBS) Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global B Streptococcus (GBS) Infection Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Type, 2020 (%)
  • Prenatal-onset GBS Disease
  • Early-onset GBS Disease
  • Late-onset GBS Disease
China B Streptococcus (GBS) Infection Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Application, 2020 (%)
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global B Streptococcus (GBS) Infection Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total B Streptococcus (GBS) Infection Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total B Streptococcus (GBS) Infection Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Pfizer Inc.
  • Alopexx Pharmaceuticals, LLC
  • Wellstat Vaccines LLC
  • Minervax ApS
  • Novartis
  • GlaxoSmithKline
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 B Streptococcus (GBS) Infection Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global B Streptococcus (GBS) Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL B STREPTOCOCCUS (GBS) INFECTION TREATMENT OVERALL MARKET SIZE

2.1 Global B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2027
2.2 Global B Streptococcus (GBS) Infection Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top B Streptococcus (GBS) Infection Treatment Players in Global Market
3.2 Top Global B Streptococcus (GBS) Infection Treatment Companies Ranked by Revenue
3.3 Global B Streptococcus (GBS) Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 B Streptococcus (GBS) Infection Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies B Streptococcus (GBS) Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 B Streptococcus (GBS) Infection Treatment Players in Global Market
  3.6.1 List of Global Tier 1 B Streptococcus (GBS) Infection Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 B Streptococcus (GBS) Infection Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global B Streptococcus (GBS) Infection Treatment Market Size Markets, 2021 & 2027
  4.1.2 Prenatal-onset GBS Disease
  4.1.3 Early-onset GBS Disease
  4.1.4 Late-onset GBS Disease
4.2 By Type - Global B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
  4.2.1 By Type - Global B Streptococcus (GBS) Infection Treatment Revenue, 2016-2021
  4.2.2 By Type - Global B Streptococcus (GBS) Infection Treatment Revenue, 2022-2027
  4.2.3 By Type - Global B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2027
  5.1.2 Hospitals Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
  5.2.1 By Application - Global B Streptococcus (GBS) Infection Treatment Revenue, 2016-2021
  5.2.2 By Application - Global B Streptococcus (GBS) Infection Treatment Revenue, 2022-2027
  5.2.3 By Application - Global B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2027
6.2 By Region - Global B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
  6.2.1 By Region - Global B Streptococcus (GBS) Infection Treatment Revenue, 2016-2021
  6.2.2 By Region - Global B Streptococcus (GBS) Infection Treatment Revenue, 2022-2027
  6.2.3 By Region - Global B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
  6.3.2 US B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.3.3 Canada B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.3.4 Mexico B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
  6.4.2 Germany B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.4.3 France B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.4.4 U.K. B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.4.5 Italy B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.4.6 Russia B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.4.8 Benelux B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
  6.5.2 China B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.5.3 Japan B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.5.4 South Korea B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.5.6 India B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
  6.6.2 Brazil B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.6.3 Argentina B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
  6.7.2 Turkey B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.7.3 Israel B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
  6.7.5 UAE B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer Inc.
  7.1.1 Pfizer Inc. Corporate Summary
  7.1.2 Pfizer Inc. Business Overview
  7.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Major Product Offerings
  7.1.4 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
  7.1.5 Pfizer Inc. Key News
7.2 Alopexx Pharmaceuticals, LLC
  7.2.1 Alopexx Pharmaceuticals, LLC Corporate Summary
  7.2.2 Alopexx Pharmaceuticals, LLC Business Overview
  7.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Major Product Offerings
  7.2.4 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
  7.2.5 Alopexx Pharmaceuticals, LLC Key News
7.3 Wellstat Vaccines LLC
  7.3.1 Wellstat Vaccines LLC Corporate Summary
  7.3.2 Wellstat Vaccines LLC Business Overview
  7.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Major Product Offerings
  7.3.4 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
  7.3.5 Wellstat Vaccines LLC Key News
7.4 Minervax ApS
  7.4.1 Minervax ApS Corporate Summary
  7.4.2 Minervax ApS Business Overview
  7.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Major Product Offerings
  7.4.4 Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
  7.4.5 Minervax ApS Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis B Streptococcus (GBS) Infection Treatment Major Product Offerings
  7.5.4 Novartis B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
  7.5.5 Novartis Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
  7.6.5 GlaxoSmithKline Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. B Streptococcus (GBS) Infection Treatment Market Opportunities & Trends in Global Market
Table 2. B Streptococcus (GBS) Infection Treatment Market Drivers in Global Market
Table 3. B Streptococcus (GBS) Infection Treatment Market Restraints in Global Market
Table 4. Key Players of B Streptococcus (GBS) Infection Treatment in Global Market
Table 5. Top B Streptococcus (GBS) Infection Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global B Streptococcus (GBS) Infection Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global B Streptococcus (GBS) Infection Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies B Streptococcus (GBS) Infection Treatment Product Type
Table 9. List of Global Tier 1 B Streptococcus (GBS) Infection Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B Streptococcus (GBS) Infection Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product Offerings
Table 32. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Alopexx Pharmaceuticals, LLC Corporate Summary
Table 34. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product Offerings
Table 35. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Wellstat Vaccines LLC Corporate Summary
Table 37. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product Offerings
Table 38. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Minervax ApS Corporate Summary
Table 40. Minervax ApS B Streptococcus (GBS) Infection Treatment Product Offerings
Table 41. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Novartis Corporate Summary
Table 43. Novartis B Streptococcus (GBS) Infection Treatment Product Offerings
Table 44. Novartis B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2016-2021)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product Offerings
Table 47. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. B Streptococcus (GBS) Infection Treatment Segment by Type
Figure 2. B Streptococcus (GBS) Infection Treatment Segment by Application
Figure 3. Global B Streptococcus (GBS) Infection Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue in 2020
Figure 8. By Type - Global B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 12. US B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 16. Germany B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 24. China B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novartis B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications